Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Immunology Research"
DOI: 10.1158/2326-6066.cir-22-0283
Abstract: Immune-inflamed cancers can be responsive to immunotherapies; however, their granular characterization is challenging. iBRIDGE integrates and ‘bridges’ bulk and scRNA-seq datasets and can be used to identify cell-type specific markers of immune-inflamed tumors in multiple…
read more here.
Keywords:
cell;
type specific;
specific markers;
inflamed tumors ... See more keywords